Your session is about to expire
← Back to Search
Procedure
LithoVue Elite Ureteroscope for Kidney Stones (LVE Trial)
N/A
Recruiting
Led By Naeem Dr Bhojani, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age > 18 years
Patient scheduled for ureteroscopy and laser lithotripsy
Must not have
Renal anomalies
Age < 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and in the recovery room after surgery
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a new type of ureteroscope that has pressure-sensing ability. The goal is to see if this new scope can reduce pain and complications related to kidney stones.
Who is the study for?
This trial is for adults over 18 with kidney stones that are not causing a blockage and measure 2 cm or less in total diameter. It's not for those under 18, pregnant individuals, people with unusual kidney shapes, severe swelling of the kidneys, or those who have a tube inserted to drain their kidney.
What is being tested?
The study is testing the LithoVue Elite ureteroscope—a new disposable scope with pressure sensing abilities—during surgery to remove kidney stones using lasers. The goal is to see how it affects pain levels, quality of life, and risk of infection.
What are the potential side effects?
While specific side effects aren't listed for the device itself, typical risks from ureteroscopy procedures include discomfort during urination, minor bleeding in urine, possible infections and rarely injury to the ureters.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
I am scheduled for a procedure to remove kidney stones using lasers.
Select...
I have a kidney stone smaller than 2 cm and am getting a flexible ureteroscopy.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have kidney abnormalities.
Select...
I am under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, 1-2 weeks after surgery and 4-8 weeks after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 1-2 weeks after surgery and 4-8 weeks after surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
WISQOL
Secondary study objectives
BPI
Change in neutrophil gelatinase-associated lipocalin (NGAL) from baseline
Complications
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Ureteroscopy (URS) with the LithoVue Elite disposable flexible ureteroscopeExperimental Treatment1 Intervention
Ureteroscopy will be done using the LithoVue Elite disposable flexible ureteroscope instead of the satandard ureteroscope
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
377 Previous Clinical Trials
131,370 Total Patients Enrolled
3 Trials studying Kidney Stones
193 Patients Enrolled for Kidney Stones
Western University, CanadaOTHER
253 Previous Clinical Trials
58,422 Total Patients Enrolled
University of British ColumbiaOTHER
1,466 Previous Clinical Trials
2,485,306 Total Patients Enrolled
13 Trials studying Kidney Stones
4,581 Patients Enrolled for Kidney Stones
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have kidney abnormalities.I am older than 18 years.I am under 18 years old.I am scheduled for a procedure to remove kidney stones using lasers.You are pregnant.I have a kidney stone smaller than 2 cm and am getting a flexible ureteroscopy.I have severe kidney swelling that makes treating my kidney stones difficult.You have a tube in your kidney to help drain urine.
Research Study Groups:
This trial has the following groups:- Group 1: Ureteroscopy (URS) with the LithoVue Elite disposable flexible ureteroscope
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger